Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates

SAN CARLOS - Iovance Biotherapeutics, Inc. , a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte therapies for...

Related Keywords

Australia ,Canada ,United Kingdom ,Sara Pellegrino ,Iovance Amtagvi ,Frederick Vogt ,European Medicines Agency ,Drug Administration ,European Union ,Exchange Commission ,Iovance Biotherapeutics Inc ,Nasdaq ,Iovance Cell Therapy Center ,Interim President ,Chief Executive Officer ,Fourth Quarter ,Launch Highlights ,New Markets ,Clinical Pipeline ,Private Securities Litigation Reform Act ,Risk Factor ,Annual Report ,Quarterly Reports ,Medicines Agency ,News Publishing ,Markets ,